Downloads provided by UsageCounts
Head-to-head comparison of available commercial antibodies against Equilibrative nucleoside transporter 1 SLC29A1 (ENT1) by immunoblot (Western blot), and immunofluorescence. Work performed in collaboration with the RESOLUTE consortium (re-solute.eu). RESOLUTE received support from the EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking (RESOLUTE grant No 777372).
Equilibrative nucleoside transporter 1, antibody characterization, Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter, Nucleoside transporter es-type, Q99808, SLC29A1, antibody validation, ENT1, Equilibrative NBMPR-sensitive nucleoside transporter, Solute carrier family 29 member 1
Equilibrative nucleoside transporter 1, antibody characterization, Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter, Nucleoside transporter es-type, Q99808, SLC29A1, antibody validation, ENT1, Equilibrative NBMPR-sensitive nucleoside transporter, Solute carrier family 29 member 1
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 14 | |
| downloads | 15 |

Views provided by UsageCounts
Downloads provided by UsageCounts